Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-03-27 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
2023年第一次临时股东大会会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 first extraordinary general meeting of shareholders of the company. It includes information about the meeting date, attendance, voting results on various proposals including financing plans, guarantees, business scope changes, amendments to the articles of association, and changes in directors. The document also mentions legal opinions confirming the validity of the meeting and resolutions. This is a formal announcement of voting results from a shareholder meeting, not the meeting materials themselves or a report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support this classification with high confidence.
2023-03-27 Chinese
关于召开2023年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2023 first extraordinary general meeting (临时股东大会) of the company. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including financing plans, amendments to the articles of association, and changes in directors. It also contains instructions for shareholders on registration and proxy voting. The document is not a report of the meeting results, nor is it a transcript or financial report. It is a formal notice to shareholders about the meeting and the matters to be voted on. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings.
2023-03-22 Chinese
关于控股子公司及其下属子公司开展应收账款无追索权保理业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Chongqing Pharmaceutical Holdings Co., Ltd. regarding its controlling subsidiary's plan to conduct non-recourse factoring business on accounts receivable. It includes details of the transaction, prior business activities, the 2023 transaction plan, independent directors' opinions, and references to board meeting resolutions. The document is relatively short (1081 characters) and serves as a formal disclosure of a financing-related business activity rather than a full financial report or detailed financial statements. It does not contain comprehensive financial data or results but rather an update on financing activities related to accounts receivable factoring. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-03-10 Chinese
关于召开2023年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2023 first extraordinary general meeting (临时股东大会) of Chongqing Pharmaceutical Holding Co., Ltd. It includes information about the meeting date, voting procedures, proposals to be voted on, and proxy authorization forms. The content focuses on the announcement and procedural details for the shareholders' meeting rather than the meeting materials or results. There is no indication that this is the actual meeting materials (AGM Information) or voting results (DVA). It is a formal announcement of the meeting itself, which fits the category of Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes and participation in the meeting.
2023-03-10 Chinese
章程修订对照表
Governance Information Classification · 95% confidence The document is a comparison table showing amendments to the company's articles of association (章程修订对照表). It details specific changes in the company's business scope and operational clauses. There is no indication of financial data, audit information, meeting results, or regulatory filings. The content is governance-related, specifically about the company's internal rules and structure. Therefore, it fits best under Governance Information (CGR). The document length is short but contains substantive governance content, not just an announcement or notice.
2023-03-10 Chinese
关于聘任公司副总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new company vice general manager, including details about the individual's background and confirmation of compliance with relevant laws and regulations. It does not contain financial data, audit information, or report content. It is clearly about a management change, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on this appointment, with no indication of financial results or other report types.
2023-03-10 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.